Additional file 1: Figure S1. of Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)

Fenaux, Pierre; Giagounidis, Aristoteles; Selleslag, Dominik; Beyne-Rauzy, Odile; Mittelman, Moshe; Muus, Petra; Nimer, Stephen; HellstrĂśm-Lindberg, Eva; Powell, Bayard; Guerci-Bresler, Agnes; Sekeres, Mikkael; Deeg, H.; del CaĂąizo, Consuelo; Greenberg, Peter; Shammo, Jamile; Skikne, Barry; Yu, Xujie; List, Alan

doi:10.6084/m9.figshare.c.3811405_D1.v1

13045_2017_491_MOESM1_ESM.docx (39.06 kB)

Additional file 1: Figure S1. of Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)

journal contribution

posted on 2017-06-26, 05:00 authored by Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, Odile Beyne-Rauzy, Moshe Mittelman, Petra Muus, Stephen Nimer, Eva HellstrĂśm-Lindberg, Bayard Powell, Agnes Guerci-Bresler, Mikkael Sekeres, H. Deeg, Consuelo del CaĂąizo, Peter Greenberg, Jamile Shammo, Barry Skikne, Xujie Yu, Alan List

Study populations in the MDS-003 and MDS-004 studies. Gray shaded boxes: age groups in the present analysis. LEN, lenalidomide. (DOCX 39Â kb)